Kidney Cancer Clinical Trials
Discover hundreds of clinical trials for kidney cancer.
It’s normal to have questions or be concerned after receiving a kidney cancer diagnosis. But you won’t be alone on your journey.
During your first appointment with our team, we will explain your diagnosis, review your treatment plan, and answer your questions. We encourage you to bring a family member, friend, or another caregiver with you to this appointment because you will learn a lot of important information.
At the appointment, you will:
Deciding the best course of action for treating kidney cancer and managing your unique needs requires knowledge and experience.
Our experts will closely review and discuss your case at our weekly tumor board meeting to develop a treatment plan that is unique to your diagnosis and health needs. Our tumor board includes specialists from several medical fields:
After preparing your treatment plan, our nurse navigators will help arrange all your necessary appointments.
As you prepare for your first appointment, consider asking the following questions of your kidney cancer care team:
Please call 911 if you have an emergency or urgent medical question.
If you are having symptoms of COVID-19, for your safety, please select a MyChart video visit on demand or call your primary care provider. For symptoms of COVID-19, please visit our website www.henryford.com/coronavirus.
Please note: Appointments for the COVID-19 vaccine can ONLY be scheduled through the COVID-19 vaccine button on eligible Henry Ford MyChart accounts at this time. Due to limited supply, they are only available at select locations and by appointment only. Get more details here.
Henry Ford Health System is committed to ensuring our Deaf or hard-of-hearing patients and visitors have equal access to all services. We provide the appropriate auxiliary aids and services, including qualified sign language interpreters, TTYs and other assistive listening devices, at no cost. To request assistance, call 313-916-1896 or email [email protected].